Tamoxifen Citrate 20mg

Tamoxifen Citrate (commonly known by its brand name Nolvadex) is an oral Selective Estrogen Receptor Modulator (SERM). Clinically developed for the prevention and treatment of estrogen receptor-positive ($ER+$) breast cancer in both pre- and post-menopausal women, Tamoxifen is one of the most widely studied hormone-modulating compounds in pharmacology.

Unlike Aromatase Inhibitors (which stop the creation of estrogen entirely), Tamoxifen acts as a competitive estrogen antagonist in specific tissues (such as breast tissue) while acting as an estrogen agonist in others (such as bone tissue and liver lipid metabolism). In hormone management, fertility, and post-cycle therapy (PCT) protocols, a 20mg formulation serves as a core standard dose to block estrogenic activity at the nipple tissue and stimulate natural pituitary gonadotropin output to restore endogenous testosterone production.

Key Benefits & Applications

• Direct Gynecomastia Prevention: Competitively blocks circulating estrogen from binding to estrogen receptors in mammary gland tissue, preventing or arresting estrogen-induced breast tissue enlargement (gynecomastia).

• HPTA Restoration & LH/FSH Stimulation: Blocks central estrogenic negative feedback at the hypothalamus and pituitary gland, triggering a rapid increase in Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) to restore natural testosterone production.

• Preservation of Circulating Estradiol ($E_2$): Does not inhibit the aromatase enzyme, ensuring essential systemic estrogen remains available for joint integrity, mood balance, and vascular health.

• Favorable Lipid Metabolism: Exhibits estrogenic agonist activity in the liver, which helps maintain healthier lipid profiles by supporting HDL cholesterol and reducing LDL levels.

• Bone Mineral Density Support: Functions as an estrogen agonist in skeletal tissues, helping preserve bone density during hormone-altering protocols.